The CDK2AP2 gene is located on chromosome 11 and encodes a protein that interacts with cyclin-dependent kinase 2 (CDK2). The protein is a component of the histone deacetylase NuRD complex, which is involved in chromatin remodeling . The NuRD complex is essential for regulating gene expression by modifying the structure of chromatin, making it either more or less accessible for transcription.
CDK2AP2 inhibits the cell cycle G1/S phase transition by repressing CDK2 expression and activation . It achieves this by inhibiting the interaction of CDK2 with cyclins E and A, which are necessary for the progression of the cell cycle . This repression is crucial for maintaining proper cell cycle control and preventing uncontrolled cell proliferation, which can lead to cancer.
Additionally, CDK2AP2 plays a role in regulating the self-renewal of embryonic stem cells and maintaining cell survival during their terminal differentiation . It also regulates microtubule organization in metaphase II oocytes, which is important for proper cell division .
Human recombinant CDK2AP2 is used in research to study its role in cell cycle regulation and chromatin remodeling. Understanding the function and regulation of CDK2AP2 can provide insights into the mechanisms of cell cycle control and the development of cancer. Additionally, it can aid in the development of therapeutic strategies targeting CDK2AP2 for the treatment of diseases associated with its dysregulation.